169 related articles for article (PubMed ID: 35526275)
1. A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening.
Dennison RA; Boscott RA; Thomas R; Griffin SJ; Harrison H; John SD; Moorthie SA; Morris S; Rossi SH; Stewart GD; Thomas CV; Usher-Smith JA
Health Expect; 2022 Aug; 25(4):1789-1806. PubMed ID: 35526275
[TBL] [Abstract][Full Text] [Related]
2. Implementation of risk stratification within bowel cancer screening: a community jury study exploring public acceptability and communication needs.
Taylor LC; Dennison RA; Griffin SJ; John SD; Lansdorp-Vogelaar I; Thomas CV; Thomas R; Usher-Smith JA
BMC Public Health; 2023 Sep; 23(1):1798. PubMed ID: 37715213
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Public Preferences for Determining Eligibility for Screening in Risk-Stratified Cancer Screening Programs: A Discrete Choice Experiment.
Dennison RA; Taylor LC; Morris S; Boscott RA; Harrison H; Moorthie SA; Rossi SH; Stewart GD; Usher-Smith JA
Med Decis Making; 2023 Apr; 43(3):374-386. PubMed ID: 36786399
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of risk stratification within population-based cancer screening from the perspective of the general public: A mixed-methods systematic review.
Taylor LC; Hutchinson A; Law K; Shah V; Usher-Smith JA; Dennison RA
Health Expect; 2023 Jun; 26(3):989-1008. PubMed ID: 36852880
[TBL] [Abstract][Full Text] [Related]
6. A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis.
Rychetnik L; Doust J; Thomas R; Gardiner R; Mackenzie G; Glasziou P
BMJ Open; 2014 Apr; 4(4):e004682. PubMed ID: 24785399
[TBL] [Abstract][Full Text] [Related]
7. Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population-based survey.
Usher-Smith JA; Harvey-Kelly LLW; Rossi SH; Harrison H; Griffin SJ; Stewart GD
Health Expect; 2021 Apr; 24(2):341-351. PubMed ID: 33264472
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of risk stratification within population-based cancer screening from the perspective of healthcare professionals: A mixed methods systematic review and recommendations to support implementation.
Taylor LC; Law K; Hutchinson A; Dennison RA; Usher-Smith JA
PLoS One; 2023; 18(2):e0279201. PubMed ID: 36827432
[TBL] [Abstract][Full Text] [Related]
9. Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.
Degeling C; Barratt A; Aranda S; Bell R; Doust J; Houssami N; Hersch J; Sakowsky R; Entwistle V; Carter SM
BMJ Open; 2018 Jun; 8(6):e021174. PubMed ID: 29903796
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study.
Jallow M; Black G; van Os S; Baldwin DR; Brain KE; Donnelly M; Janes SM; Kurtidu C; McCutchan G; Robb KA; Ruparel M; Quaife SL
Health Expect; 2022 Aug; 25(4):1776-1788. PubMed ID: 35475542
[TBL] [Abstract][Full Text] [Related]
11. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
12. Views of the Australian public on the delivery of risk-stratified cancer screening in the population: a qualitative study.
Dunlop K; Rankin NM; Smit AK; Newson AJ; Keogh LA; Cust AE
Public Health Res Pract; 2023 Jul; 33(2):. PubMed ID: 36065020
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Screening for reducing morbidity and mortality in malignant melanoma.
Johansson M; Brodersen J; Gøtzsche PC; Jørgensen KJ
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012352. PubMed ID: 31157404
[TBL] [Abstract][Full Text] [Related]
15. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
16. How a deliberative approach includes women in the decisions of screening mammography: a citizens' jury feasibility study in Andalusia, Spain.
Baena-Cañada JM; Luque-Ribelles V; Quílez-Cutillas A; Rosado-Varela P; Benítez-Rodríguez E; Márquez-Calderón S; Rivera-Bautista JM
BMJ Open; 2018 May; 8(5):e019852. PubMed ID: 29730621
[TBL] [Abstract][Full Text] [Related]
17. The ethics of risk-stratified cancer screening.
Dennison RA; Usher-Smith JA; John SD
Eur J Cancer; 2023 Jul; 187():1-6. PubMed ID: 37094523
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
19. Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.
Hawkins R; McWilliams L; Ulph F; Evans DG; French DP
BMC Cancer; 2022 Oct; 22(1):1058. PubMed ID: 36224549
[TBL] [Abstract][Full Text] [Related]
20. Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
McWilliams L; Woof VG; Donnelly LS; Howell A; Evans DG; French DP
BMC Cancer; 2021 May; 21(1):637. PubMed ID: 34051753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
